Midgard Science

WuXi STA

Changzhou, China sta.wuxiapptec.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

WuXi STA provides contract development and manufacturing services for small-molecule and synthetic-molecule pharmaceuticals. It serves clients globally from facilities across Asia, North America, and Europe, supporting projects from preclinical through commercial stages.

Services

  • API process development

    Develops synthetic routes and process R&D for starting materials, intermediates, and active pharmaceutical ingredients from preclinical to commercial launch.

  • API manufacturing

    Manufactures small-molecule intermediates, building blocks, and drug substance from gram to metric-ton scale.

  • High potency API

    Provides process R&D and manufacturing for high-potency APIs, including facilities handling HP compounds with an OEL of 10 ng/m3.

  • Flow chemistry

    Offers process development, non-GMP, and GMP production services using continuous manufacturing flow chemistry.

  • Biocatalysis

    Uses enzyme-based biocatalysis for stereoselective biotransformations and enantiomer resolutions.

  • Drug product oral solid development

    Supports pre-formulation, formulation development, and manufacturing for oral solid dosage forms.

  • Pre-formulation

    Studies physicochemical properties to support selection of developable molecules at the preclinical stage.

  • Formulation development

    Develops oral solid formulations from preclinical to commercial manufacturing.

19 more services
  • Oral solid state development
  • Drug product parenteral development
  • Parenteral manufacturing
  • Clinical supply service
  • Analytical development and quality control
  • Regulatory CMC dossier preparation
  • Spray dried dispersion
  • Process Development
  • Manufacturing
  • Preparative HPLC, SFC, and SMB
  • Crystallization and Particle Engineering
  • Drug Product Development
  • Parenteral Development
  • Lipid Nanoparticle Platform
  • Hot Melt Extrusion
  • Lipid Formulation
  • Nano Suspension
  • Reference Standard Characterization and Qualification
  • Regulatory Dossier Preparation
Lead time
6-8 weeks to prepare IND submission package for US FDA
What to send
  • Work Email
  • Company / Institution
  • Country / Region

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • Peptide
  • Oligonucleotide
  • LNP / formulation
  • LNP
  • Process development
3 more
  • HPLC
  • Analytical development
  • Stability studies
Capacity
  • Few grams to metric ton scale
  • OEL of 10 ng/m3
  • 5 production lines
  • Total reactor volume exceeds 4,000 m3
  • 6 sites in Asia and North America
  • 3,600+ process chemists and analytical scientists
7 more
  • 1,500+ formulators & analytical scientists
  • 3,500+ analytical scientists
  • OEL ≥10 ng/m³
  • 2024: 1,000+ preclinical-phase III molecules supported
  • 50+ late-phase NCEs validated
  • 10+ commercial products supported
  • 740+ CMC submission packages written during 2019-2024
Scales
Gram · Kilogram · Ton
Data supplied
HPLC

Equipment

  • Prep-HPLC
  • SFC
  • SMB
  • Spray dryers

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Team
3,600+ process chemists and analytical scientists; 1,500+ formulators & analytical scientists; 3,500+ analytical scientists
Office
Manufacturing 20+ years' experience Over 20 years of experience in API manuf
Sites
  • Shanghai Waigaoqiao, China
  • Shanghai, China
  • Wuxi City, China
  • Taixing, China
  • Jinshan, China
  • Tuas, Singapore
4 more
  • Middletown, Delaware, USA
  • San Diego, California, USA
  • Couvet, Neuchâtel, Switzerland
  • Shanghai Jinshan, China
Serves
Globally, Asia, North America, Europe, 105 countries, worldwide

Similar labs